Showing 23 companies
Brightspark
Brightspark
Angel Investing
Angel Investment
Crowdfunding
Enterprise Software
Finance
Financial Services
Lending and Investments
Lending and Investments
Mobile
Technology
Venture Capital
Venture Capital and Private Equity Principals
Venture Capital & Private Equity

Brightspark Ventures invests in early-stage Canadian software companies. Brightspark has been investing in the Canadian VC industry since 1999. Over the last 20 years, the company has refined its focus to the point where it chooses what it believes to be the best early-stage opportunities in the market. The company's goal is to find exceptional startups and work closely with these companies as they grow to achieve stellar returns. We have structured our investments to allow individual accredited investors to invest with us. We have found that individual investors share the same goals as us when investing: they too want to invest in startups with CEOs that are focused on creating massive returns. This model also benefits our portfolio companies, who appreciate having a network of investors they don’t necessarily have to manage. By leading the investment and actively working as the gatekeeper for the company, Brightspark ensures that the company can grow to its full potential without being distracted or becoming unfocused. This model attracts some of the best companies in Canada.

DrugBank
DrugBank
Pre Seed
Analytics
Biotechnology
Health Care
Pharmaceutical
Technology, Information and Internet

DrugBank augments human intelligence to improve the world’s health. Our suite of products is powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine or clinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions. Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free to use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.